Replay available

Beta Bionics, Inc. (BBNX) Q1 2026 Earnings Call

Beta Bionics, Inc. (NASDAQ: BBNX) Q1 2026 earnings conference call, held 2026-04-21. Replay captured from the company's public earnings webcast.

Tue, April 21, 2026 at 4:30 PMendedReplay
Beta Bionics, Inc. (BBNX) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Blake Bieber

Head of Investor Relations

Sean Saint

Chief Executive Officer

Stephen Feider

Chief Financial Officer

Mike Crackey

Analyst, LeRig Partners

David Roman

Analyst, Goldman Sachs

Frank Takanan

Analyst, Lake Street Capital Markets

John Block

Analyst, Stiefel

Jeff Johnson

Analyst, Baird

Matthew O'Brien

Analyst, Piper Sandler

Jeffrey Cohen

Analyst, Lattemberg Thalman & Company

Matthew Blackman

Analyst, TD Cowen

Ryan Schiller

Analyst, Wolfe Research

Replay transcript excerpt

Good afternoon, and welcome to the Beta Bionics First Quarter twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded. I would now like to hand the conference over to Blake Bieber, Head of Investor Relations. You may begin, sir. Good afternoon, and thank you for tuning in to Beta Bionics' first quarter twenty twenty six earnings call. Joining me on today's call are Chief Executive Officer, Sean Saint and Chief Financial Officer, Steven Feider. Both the replay of this call and the press release discussing our first quarter twenty twenty six results will be available on the Investor Relations section of our website. Information recorded on this call speaks only as of today, 04/21/2026. Therefore, if you are listening to the replay, any time sensitive information may no longer be accurate. Also on our website is our supplemental first quarter twenty twenty six earnings presentation and updated corporate presentation. We encourage you to refer to those documents for a summary of key metrics and business updates. Before we begin, we'd like to remind you that today's discussion will include forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance and operating plans. Please refer to the cautionary statements in the press release we issued earlier today for a detailed explanation of the inherent limitations of such forward looking statements. These docume...

More from Beta Bionics, Inc.